Carl S.
Carl is a Fulbright Scholar at the University of Tokyo to engineer tools for brain imaging. Before moving abroad, he majored in Biology and minored in Chemistry at the University of Houston, receiving distinction for his research accomplishments and graduating with a 4.0 GPA.
Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
King
King is currently an MD student at Harvard. He earned his BA in Sociology and Health from University Notre Dame, and earned a MS in Global Public Health and Policy at Queen Mary University of London.